Liver histologic features play a crucial role in forecasting long-term clinical outcomes in patients with MASLD and its ...
Women in midlife with moderate-to-severe vasomotor symptoms have an increased risk for metabolic dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, ...
The article, “Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer ...
Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom ...
Of particular concern is the finding that nearly 35% of the cases are among children, now referred to as metabolic ...
only steatohepatitis. MetaDeq is committed to delivering diagnostics that help physicians identify, diagnose, stage and monitor MASLD and MASH patients with a simple and accurate blood test. MetaDeq's ...
Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom ...
GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and ...
In the second oral presentation, Dr. Timothy Kendall will share the improved performance of predictive indices of all-cause mortality and hepatic decompensation derived from quantified fibrosis ...
Children who are sedentary for more than six waking hours a day have a significantly increased risk of severe fatty liver ...
PGIMER’s average outpatient department (OPD) numbers are above 10,000 a day, and some departments like internal medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results